search
Back to results

Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse (YMHP)

Primary Purpose

HIV Infections

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Clinic-based Delivery
Remote Delivery
Multi-modal Delivery
Sponsored by
Florida State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV Infections focused on measuring HIV, Intervention, Men Who Have Sex with Men (MSM), PrEP, YMHP, YMSM

Eligibility Criteria

15 Years - 24 Years (Child, Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • HIV-negative test result from the past 90 days
  • 15-24 years of age
  • Born biologically male or currently identifying as male
  • Sex with men in the past 90 days
  • ≥ 3 days of illicit drug use in the past 90 days
  • ≥ 1 episode of Condomless Anal Sex (CAS) in the past 90 days, or a positive STI test result in the past 90 days.
  • Able to communicate in English

Exclusion Criteria:

  • Serious cognitive or psychiatric impairments
  • Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)

Sites / Locations

  • University of Miami Miller School of Medicine
  • Wayne State University
  • Children's Hospital of Philadelphia

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

No Intervention

Arm Label

Clinic-based Delivery

Remote Delivery

Multi-modal Delivery

Treatment as Usual

Arm Description

Participants will receive the intervention in person following HIV counseling and testing. The intervention involves completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis (PrEP) information and navigation services to interested participants. This arm is closed to enrollment.

Participants will receive the intervention by remote delivery following HIV counseling and testing. Just as the clinic-based participants, he intervention involves completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis (PrEP) information and navigation services to interested participants. This arm is closed to enrollment.

A 4 session MI intervention. Session 1 is always delivered in person immediately after baseline. Session 2-4 can be delivered in person or remotely based upon youth preference. This arm is open to enrollment as of 11/15/2019.

Treatment as usual control = individual HIV testing with referrals and link age to care as provided by the sites under routine circumstances. This arm is open to enrollment as of 11/15/2019.

Outcomes

Primary Outcome Measures

Sexual Self Management Change
Computer Assisted Self Interview (CASI) scored through Qualtrics
Sexual Health Management Change
Serologic lab test of blood sample - positive or negative for HIV and other Sexually Transmitted Infections (STIs)
Substance Abuse Change
Nucleic Acid Amplification (NAA) Urinalysis Drug Screen

Secondary Outcome Measures

Full Information

First Posted
April 6, 2018
Last Updated
September 6, 2022
Sponsor
Florida State University
search

1. Study Identification

Unique Protocol Identification Number
NCT03577301
Brief Title
Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
Acronym
YMHP
Official Title
Comparative Effectiveness Trial of Clinic-Based Delivery of an HIV Risk Reduction Intervention for Young Men Who Have Sex With Men (YMSM)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
October 4, 2018 (Actual)
Primary Completion Date
May 31, 2022 (Actual)
Study Completion Date
May 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Florida State University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
YMHP is a counseling intervention program for which the goals are to better understand HIV-prevention focused self-management behaviors among HIV-negative YMSM, and to study the implementation of YMHP to improve portability and scalability. The clinic sites will help investigators to assess and address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce HIV infection among YMSM that reflects the complexities of real world adolescent HIV clinics.
Detailed Description
Adapt YMHP for clinic and phone delivery by existing HIV clinic staff community health workers (CHWs), who work with YMSM ages 15-24. Investigators will conduct focus groups with staff to obtain input on how best to implement YMHP to maximize feasibility, acceptability, and sustainability, as well as issues with adapting the YMHP for delivery to YMSM ages 15-18 and for phone delivery. Compare the effectiveness of clinic-based versus phone-based delivery of YMHP in the context of health care access. In order to inform future implementation, investigators will test the effectiveness of YMHP delivered via these two modalities. Assess the cost-effectiveness of both delivery formats of YMHP to enhance the likelihood of uptake of this best evidence intervention. The hypothesis is that phone-based will be more cost-effective than clinic-based Assess the Five Components of the Self-Management Model and how these components vary over time, are directly improved by the interventions, and mediate intervention effects. Test a sustainable model of YMHP implementation in real world adolescent clinics. Investigators will utilize local supervisors within the clinic setting to sustain the CHWs fidelity to delivering the motivational interviewing (MI)-based YMHP intervention. Fidelity will be monitored throughout the trial and assessments and qualitative interviews will be conducted with key stakeholders to determine the barriers and facilitators of YMHP implementation utilizing the Exploration, Preparation, Implementation, Sustainment model (EPIS). Aims will be achieved over two phases of the study. Phase I: Investigators will conduct research (Exploration and Preparation phases of EPIS model) to obtain implementation feedback to best adapt YMHP for clinic-based CHWs, further incorporate PrEP navigation services, and expand the YMHP protocol to be relevant for Telephone-based Motivational Interviewing (TBMI). We will train a minimum of 2 CHWs at each clinic drawing on the Implementation Science Core (ISC) to apply best-practices in training. Once CHWs demonstrate competence according to the Motivational Interviewing Treatment Integrity (MITI), Phase 2 will begin. Phase II: Personnel will recruit and enroll 180 YMSM, ages 15-24, 60 at each of the three sites. Sessions will be audio-recorded for MITI fidelity coding, and CHWs and supervisors will be given implementation support throughout. Prior to implementation, immediately at the conclusion of the intervention delivery phase, and one year after, the ISC will conduct interviews with CHWs, supervisors, and clinic leaders to obtain information about the barriers and facilitators of implementation and sustainment. Target n: 180 YMSM across three sites (60 per site).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
HIV, Intervention, Men Who Have Sex with Men (MSM), PrEP, YMHP, YMSM

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
83 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Clinic-based Delivery
Arm Type
Active Comparator
Arm Description
Participants will receive the intervention in person following HIV counseling and testing. The intervention involves completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis (PrEP) information and navigation services to interested participants. This arm is closed to enrollment.
Arm Title
Remote Delivery
Arm Type
Active Comparator
Arm Description
Participants will receive the intervention by remote delivery following HIV counseling and testing. Just as the clinic-based participants, he intervention involves completion of the 4 YMHP sessions and the delivery of pre-exposure prophylaxis (PrEP) information and navigation services to interested participants. This arm is closed to enrollment.
Arm Title
Multi-modal Delivery
Arm Type
Active Comparator
Arm Description
A 4 session MI intervention. Session 1 is always delivered in person immediately after baseline. Session 2-4 can be delivered in person or remotely based upon youth preference. This arm is open to enrollment as of 11/15/2019.
Arm Title
Treatment as Usual
Arm Type
No Intervention
Arm Description
Treatment as usual control = individual HIV testing with referrals and link age to care as provided by the sites under routine circumstances. This arm is open to enrollment as of 11/15/2019.
Intervention Type
Behavioral
Intervention Name(s)
Clinic-based Delivery
Intervention Description
A minimum of 2 community health workers (CHWs) will be trained to deliver clinic-based intervention sessions.
Intervention Type
Behavioral
Intervention Name(s)
Remote Delivery
Intervention Description
A minimum of 2 community health workers (CHWs) will be trained to deliver intervention sessions to the participant in a location remote from the clinic setting.
Intervention Type
Behavioral
Intervention Name(s)
Multi-modal Delivery
Intervention Description
A minimum of 2 community health workers (CHWs) will be trained to deliver clinic-based or remote intervention sessions. First MI session is in person immediately after baseline. Sessions 2-4 can be delivered in person or remotely based on youth preference.
Primary Outcome Measure Information:
Title
Sexual Self Management Change
Description
Computer Assisted Self Interview (CASI) scored through Qualtrics
Time Frame
3 Month Interval
Title
Sexual Health Management Change
Description
Serologic lab test of blood sample - positive or negative for HIV and other Sexually Transmitted Infections (STIs)
Time Frame
3 Month Interval
Title
Substance Abuse Change
Description
Nucleic Acid Amplification (NAA) Urinalysis Drug Screen
Time Frame
3 Month Interval

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
Born biologically male or currently identifying as male
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: HIV-negative test result from the past 90 days 15-24 years of age Born biologically male or currently identifying as male Sex with men in the past 90 days ≥ 3 days of illicit drug use in the past 90 days ≥ 1 episode of Condomless Anal Sex (CAS) in the past 90 days, or a positive STI test result in the past 90 days. Able to communicate in English Exclusion Criteria: Serious cognitive or psychiatric impairments Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sylvie Naar, PhD
Organizational Affiliation
Florida State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Miami Miller School of Medicine
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States
Facility Name
Wayne State University
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Facility Name
Children's Hospital of Philadelphia
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse

We'll reach out to this number within 24 hrs